Clinical trial
Perioperative Melatonin and Other Neuroinflammatory Biomarkers for Predicting Postoperative Delirium in Older Adults Undergoing Elective Abdominal Cancer Surgery
NCT07859488 is registered in ClinicalTrials.gov with Fatma Cigdem Ozakin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Perioperative Melatonin and Other Neuroinflammatory Biomarkers for Predicting Postoperative Delirium in Older Adults Undergoing Elective Abdominal Cancer Surgery
- Lead sponsor
- Fatma Cigdem Ozakin
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 1, 2026
- Completion date
- September 6, 2027
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
abdominal neoplasms, postoperative delirium (pod)